G Dangas

Summary

Affiliation: Cardiovascular Research Foundation
Country: USA

Publications

  1. ncbi request reprint Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)
    George Dangas
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 94:983-8. 2004
  2. ncbi request reprint Transient contrast encephalopathy after carotid artery stenting
    G Dangas
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Endovasc Ther 8:111-3. 2001
  3. ncbi request reprint Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study)
    George Dangas
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:659-63. 2005
  4. ncbi request reprint Prognostic importance of myonecrosis after percutaneous coronary interventions
    G Dangas
    Cardiovascular Research Foundation, New York, NY, USA
    J Invasive Cardiol 13:247-50; discussion 266-70. 2001
  5. ncbi request reprint Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy
    G Dangas
    Knox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, New York, New York 10022, USA
    J Endovasc Ther 8:39-43. 2001
  6. ncbi request reprint Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention
    George Dangas
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 89:586-9. 2002
  7. ncbi request reprint Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables
    George Dangas
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 95:13-9. 2005
  8. ncbi request reprint Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein grafts
    G Dangas
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 86:777-9, A6. 2000
  9. ncbi request reprint Intravascular ultrasound-guided renal artery stenting
    G Dangas
    Cardiovascular Research Foundation, New York, New York 10022, USA
    J Endovasc Ther 8:238-47. 2001
  10. ncbi request reprint Pulmonary hemorrhage during GP IIb/IIIa inhibitor therapy: an uncommon but life-threatening (and under-recognized) complication
    George Dangas
    Lenox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    J Invasive Cardiol 15:189-90. 2003

Collaborators

Detail Information

Publications93

  1. ncbi request reprint Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)
    George Dangas
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 94:983-8. 2004
    ..The incidence of early thrombosis after primary angioplasty and stenting is decreased by abciximab use...
  2. ncbi request reprint Transient contrast encephalopathy after carotid artery stenting
    G Dangas
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Endovasc Ther 8:111-3. 2001
    ..To report an unusual case of transient contrast encephalopathy arising after carotid artery stenting...
  3. ncbi request reprint Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study)
    George Dangas
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:659-63. 2005
    ....
  4. ncbi request reprint Prognostic importance of myonecrosis after percutaneous coronary interventions
    G Dangas
    Cardiovascular Research Foundation, New York, NY, USA
    J Invasive Cardiol 13:247-50; discussion 266-70. 2001
    ..Data have correlated this phenomenon with late mortality, and with diffuse atherosclerotic disease. While controversy still exists, the potential for improved mortality after PCI should be fully explored in a systematic way...
  5. ncbi request reprint Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy
    G Dangas
    Knox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, New York, New York 10022, USA
    J Endovasc Ther 8:39-43. 2001
    ..To report the results of carotid artery stenting (CAS) in patients considered to have high-risk anatomical characteristics for carotid endarterectomy...
  6. ncbi request reprint Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention
    George Dangas
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 89:586-9. 2002
  7. ncbi request reprint Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables
    George Dangas
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 95:13-9. 2005
    ..22 to 2.60). Thus, regardless of the presence of CKD, baseline characteristics and periprocedural hemodynamic parameters predict CIN, and this complication is associated with worse in-hospital and 1-year outcomes...
  8. ncbi request reprint Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein grafts
    G Dangas
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 86:777-9, A6. 2000
    ..However, this population has high long-term mortality and frequent need for repeat revascularization...
  9. ncbi request reprint Intravascular ultrasound-guided renal artery stenting
    G Dangas
    Cardiovascular Research Foundation, New York, New York 10022, USA
    J Endovasc Ther 8:238-47. 2001
    ..To evaluate the clinical outcomes of patients undergoing renal artery stenting with intravascular ultrasound (IVUS) guidance and compare measurements between IVUS and angiography...
  10. ncbi request reprint Pulmonary hemorrhage during GP IIb/IIIa inhibitor therapy: an uncommon but life-threatening (and under-recognized) complication
    George Dangas
    Lenox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    J Invasive Cardiol 15:189-90. 2003
  11. ncbi request reprint Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention
    Ioannis Iakovou
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY, 10022, USA
    J Invasive Cardiol 15:18-22. 2003
    ..Contrast-induced nephropathy (CIN) is a recognized complication after percutaneous interventions (PCI). We sought to determine the impact of gender on incidence and clinical outcome of CIN...
  12. doi request reprint Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial
    George Dangas
    Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1438-46. 2009
    ....
  13. ncbi request reprint Cardiology patient page. Restenosis: repeat narrowing of a coronary artery: prevention and treatment
    George Dangas
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 105:2586-7. 2002
  14. doi request reprint Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
    Roxana Mehran
    Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
    Lancet 374:1149-59. 2009
    ..Here, we assess whether these initial benefits were maintained at 1 year of follow-up...
  15. doi request reprint Bivalirudin during primary PCI in acute myocardial infarction
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 358:2218-30. 2008
    ..The safety and efficacy of bivalirudin in high-risk patients are unknown...
  16. ncbi request reprint Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting
    J M Ahmed
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 87:401-5. 2001
    ....
  17. ncbi request reprint Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin
    G Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA
    Am J Cardiol 84:639-43. 1999
    ..Blood thrombogenicity was reduced with pravastatin in both genders; in addition, thrombin generation was gradually reduced in women to a level similar to that of men by 6 months of follow-up...
  18. ncbi request reprint Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting
    G Dangas
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 87:470-2, A7. 2001
    ..At 30-day follow-up, there were trends toward increased subacute thrombosis with A+C compared with A+T (1.3% vs 0.2%, p = 0.10). These results suggest that A+C may have marginally higher subacute stent thrombosis than A+T...
  19. doi request reprint Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
    Gregg W Stone
    Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 360:1946-59. 2009
    ....
  20. ncbi request reprint Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results
    R Mehran
    Cardiovascular Research Foundation, 55 E 59th St, New York, NY 10022, USA
    Am Heart J 141:610-4. 2001
    ..2-4.7, P =.01). CONCLUSION: Repeat stenting for the treatment of focal ISR had a higher postprocedure creatine kinase myocardial band elevation rate and similar long-term clinical results compared with PTCA alone...
  21. doi request reprint Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)
    Kenichi Tsujita
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 105:1385-94. 2010
    ..Paradoxically, in this post hoc analysis, the reductions in major bleeding and mortality in ST elevation myocardial infarction afforded by bivalirudin occurred primarily in patients without baseline anemia...
  22. ncbi request reprint Rotational atherectomy for in-stent restenosis: acute and long-term results of the first 100 cases
    S K Sharma
    Cardiac Catheterization Laboratory of the Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
    J Am Coll Cardiol 32:1358-65. 1998
    ....
  23. ncbi request reprint Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients
    G W Stone
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York City, NY, USA
    Circulation 104:642-7. 2001
    ..Large periprocedural infarctions (signified by new Q waves and CPK-MB >8xULN) are powerful determinants of death, whereas lesser degrees of CPK-MB release and specific device use do not adversely affect survival...
  24. ncbi request reprint Intra-arterial reteplase for the treatment of acute limb ischemia
    J R Laird
    Cardiovascular Research Foundation, 110 Irving Street N W, Suite 4B 1, Washington, D C 20010, USA
    J Invasive Cardiol 11:757-62. 1999
    ..We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy...
  25. ncbi request reprint An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
    J Invasive Cardiol 19:208-13. 2007
    ..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
  26. ncbi request reprint Relation between preintervention remodeling and late arterial responses to coronary angioplasty or atherectomy
    G S Mintz
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 87:392-6. 2001
    ..This may explain that the increased clinical restenosis after positive remodeling lesions is treated with non-stent interventions...
  27. ncbi request reprint Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection
    Dale T Ashby
    Lenox Hill Heart and Vascular Institute, New York, New York, USA
    J Am Coll Cardiol 41:749-52. 2003
    ..This study was designed to investigate the impact of percutaneous coronary interventions (PCIs) in degenerated saphenous vein grafts (SVGs) without distal embolic protection...
  28. ncbi request reprint Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusions
    Yi ming Yang
    Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
    Catheter Cardiovasc Interv 63:462-8. 2004
    ..TIMI 3 flow was achieved in all target vessels after further balloon angioplasty or stenting. The Frontrunner device is a safe and effective tool in the treatment of CTOs from ISR...
  29. ncbi request reprint Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices
    G Dangas
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    J Am Coll Cardiol 38:638-41. 2001
    ..5 vs. 1.5%, p = 0.03). CONCLUSIONS: In this early experience with ACD after PCI, their use was associated with higher vascular complication rates than hemostasis with manual compression...
  30. ncbi request reprint Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis
    Kazuyuki Shirai
    Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
    Am J Cardiol 92:1409-13. 2003
    ..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
  31. ncbi request reprint Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study
    Kenichi Fujii
    Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, New York, NY 10022, USA
    J Am Coll Cardiol 45:995-8. 2005
    ..We sought to determine the predictors of stent thrombosis after sirolimus-eluting stent (SES) implantation...
  32. ncbi request reprint Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 42:1900-5. 2003
    ..We sought to determine the impact of aggressive stent expansion on creatine kinase-MB isoenzyme (CK-MB) release and clinical restenosis...
  33. ncbi request reprint Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions
    Costantino O Costantini
    Cardiovascular Research Foundation, Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, New York, NY 10022, USA
    J Am Coll Cardiol 41:1725-31. 2003
    ..We analyzed the effects of vascular brachytherapy (VBT) on ostial in-stent restenosis (ISR)...
  34. doi request reprint Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary gra
    Dinesh Kumar
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 106:941-5. 2010
    ....
  35. ncbi request reprint Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound
    Masashi Kimura
    The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:436-42. 2006
    ..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
  36. ncbi request reprint Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era
    Tereza Pucelikova
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 101:63-8. 2008
    ..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
  37. ncbi request reprint Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries
    Dale T Ashby
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
    Am J Cardiol 89:1162-6. 2002
    ..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
  38. ncbi request reprint Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 89:976-9. 2002
  39. ncbi request reprint Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect
    G Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Thromb Haemost 83:688-92. 2000
    ..Therefore, the reduction in thrombogenicity was not proportional to the magnitude of LDL-C reduction suggesting that a class or agent specific property is primarily responsible for the pro-fibrinolytic/antithrombotic effects observed...
  40. ncbi request reprint Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model
    Nicholas N Kipshidze
    Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
    Catheter Cardiovasc Interv 64:389-94. 2005
    ..001). In the porcine coronary model, site-specific systemic delivery of Rapamycin utilizing PGMC resulted in overexpression of p27 and a significant reduction of neointimal formation within the stented segments...
  41. ncbi request reprint Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10021, USA
    Circulation 109:1085-8. 2004
    ..We used intravascular ultrasound (IVUS) to evaluate recurrence after sirolimus-eluting stent (SES) implantation treatment of in-stent restenosis (ISR)...
  42. ncbi request reprint Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    Catheter Cardiovasc Interv 61:518-27. 2004
    ..In the porcine coronary model, an advanced c-myc-eluting PC stent blocked c-myc expression and significantly inhibited myointimal hyperplasia and allowed complete reendothelialization and healing response...
  43. ncbi request reprint Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery
    Ioannis Iakovou
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 90:885-7. 2002
  44. ncbi request reprint Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 95:355-9. 2005
    ..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
  45. ncbi request reprint A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation
    Roxana Mehran
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10022, USA
    J Am Coll Cardiol 44:1393-9. 2004
    ..We sought to develop a simple risk score of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI)...
  46. doi request reprint Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents
    Eugenia Nikolsky
    Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Catheter Cardiovasc Interv 71:896-906. 2008
    ..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...
  47. ncbi request reprint Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old
    Yoshio Kobayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:443-6. 2003
    ....
  48. ncbi request reprint Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion
    Hideo Takebayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Catheter Cardiovasc Interv 60:496-9. 2003
    ..This case report describes in-stent restenosis due to stent underexpansion after kissing stents using sirolimus-eluting stents...
  49. ncbi request reprint The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention
    Adam J Saltzman
    Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
    J Invasive Cardiol 22:2-6. 2010
    ..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
  50. ncbi request reprint Relation between the degree of procedural anticoagulation and complications after coronary stent implantation
    Dale T Ashby
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:319-22. 2003
    ..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
  51. ncbi request reprint Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy
    Costantino O Costantini
    Cardiovascular Research Foundation, New York, New York 10021, USA
    Am J Cardiol 92:1214-7. 2003
    ....
  52. ncbi request reprint Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials
    Somjot S Brar
    Columbia University Medical Center, New York, NY, USA
    EuroIntervention 5:475-84. 2009
    ....
  53. ncbi request reprint Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries
    Dale T Ashby
    Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    Am J Cardiol 91:979-81, A4, A7. 2003
  54. doi request reprint The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale
    Roxana Mehran
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
    Am Heart J 156:44-56. 2008
    ..Newer pharmacologic agents and drug-eluting stents may address both of these issues...
  55. ncbi request reprint Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction
    Gregg W Stone
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 39:591-7. 2002
    ..We sought to evaluate and validate the ability of the angiographic myocardial blush grade to risk stratify patients after successful angioplasty in acute myocardial infarction (AMI)...
  56. doi request reprint Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome
    Jeffrey W Moses
    Center for Interventional Vascular Therapy, Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 102:24J-8J. 2008
    ..Ensuring adequate stent dimensions and wall contact can contribute to successful outcomes in patients receiving SES...
  57. ncbi request reprint Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation
    Alexandra J Lansky
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 39:274-80. 2002
    ....
  58. ncbi request reprint Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis
    Koichi Sano
    Cardiovascular Research Foundation, 611 Pennsylvania Avenue, S E, No 386, Washington, D C, USA
    J Invasive Cardiol 19:464-8. 2007
    ..The intravascular ultrasound (IVUS) findings during repeat intervention for drug-eluting stent (DES) restenosis have not been well described...
  59. ncbi request reprint Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 148:764-75. 2004
    ..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
  60. ncbi request reprint Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis
    Yoshio Kobayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:1329-31. 2003
    ..02) but similar target vessel revascularization (35.1% vs 29.8%, p = 0.4) at follow-up...
  61. ncbi request reprint New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registry
    Alexandra J Lansky
    Cardiac Catheterization Laboratory and the Women s Cardiac Health Initiative, Lenox Hill Hospital, New York City, NY 10022, USA
    Epidemiology 13:S46-51. 2002
    ..To gain insight into the outcome of women after new-device angioplasty, we reviewed the early and late clinical outcome of 7,372 patients undergoing new-device angioplasty between 1991 and 1996 at the Washington Hospital Center...
  62. ncbi request reprint Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, 130 East 77th St, 9th Floor, New York, NY 10021, USA
    Circulation 108:2473-8. 2003
    ..It is not clear why some plaque ruptures lead to acute coronary syndromes (ACS) but others do not...
  63. ncbi request reprint Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age
    Alexandra J Lansky
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 93:916-9. 2004
    ....
  64. ncbi request reprint Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:1171-6. 2003
    ..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
  65. ncbi request reprint Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patients
    Zoran Lasic
    Department of Interventional Cardiology, Lenox Hill Hospital, 100 East 77th Street, New York, NY 10021, USA
    J Invasive Cardiol 16:356-8. 2004
    ..This study found that the new Angio-Seal STS Platform device can secure hemostasis after PCI in a safe and effective manner similar to the old device. The new platform is easier for the operator and for the patients...
  66. ncbi request reprint Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%
    Makoto Hirose
    Cardiovascular Research Foundation, New York, NY 10021, USA
    Am J Cardiol 92:141-5. 2003
    ..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
  67. ncbi request reprint One-year clinical outcome after minimally invasive direct coronary artery bypass
    R Mehran
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Circulation 102:2799-802. 2000
    ..Minimally invasive coronary artery bypass (MIDCAB) is a new surgical technique by which the left internal mammary artery is anastomosed under direct visualization to the left anterior descending artery without cardiopulmonary bypass...
  68. ncbi request reprint Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography
    G Dangas
    Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA
    Coron Artery Dis 11:409-14. 2000
    ..To study the impact of detection of viability of myocardium in asymptomatic patients early (3-10 days) after Q-wave myocardial infarction on segmental recovery of left ventricular function after elective revascularization...
  69. ncbi request reprint Contrast-induced nephropathy
    Tereza Pucelikova
    Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, New York 10022, USA
    Catheter Cardiovasc Interv 71:62-72. 2008
    ....
  70. doi request reprint Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome
    Eduardo Missel
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 101:573-8. 2008
    ..01) than patients with no predictors. In conclusion, VH-IVUS analysis showed that the percentage of NC and its ratio to DC in diseased coronary segments are positively associated with a high-risk ACS presentation...
  71. ncbi request reprint Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis
    Eugenia Nikolsky
    Cardiovascular Research Foundation and the Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 44:1200-9. 2004
    ..This study was designed to assess the safety of arteriotomy closure devices (ACDs) versus mechanical compression by meta-analysis in patients undergoing percutaneous transfemoral coronary procedures...
  72. ncbi request reprint Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)
    Thosaphol Limpijankit
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 92:315-8. 2003
    ..e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events...
  73. ncbi request reprint Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon
    Jose de Ribamar Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 100:812-7. 2007
    ..In conclusion, in this observational, nonrandomized study, pretreatment with the AngioSculpt balloon enhanced stent expansion and minimized the difference between predicted and achieved stent dimensions...
  74. ncbi request reprint Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomes
    Roxana Mehran
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Catheter Cardiovasc Interv 61:354-9. 2004
    ..Lesion length remains a powerful predictor of recurrent ISR and clinical events after treatment of ISR even with gamma-RT...
  75. ncbi request reprint Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery
    George Dangas
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 45:1186-92. 2005
    ..We sought to examine the efficacy of paclitaxel-eluting stent implantation in the left anterior descending coronary artery (LAD)...
  76. ncbi request reprint Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture
    Lisette Okkels Jensen
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 152:327-32. 2006
    ..Although intravascular ultrasound (IVUS) can detect plaque rupture, the fibrous cap remnant has not previously been studied in detail. The aim of the present study is to assess the fibrous cap remnants by IVUS in ruptured plaques...
  77. ncbi request reprint Coronary artery stenting
    Dale T Ashby
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Catheter Cardiovasc Interv 56:83-102. 2002
  78. ncbi request reprint Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Catheter Cardiovasc Interv 62:303-7. 2004
    ..DM remains a powerful predictor of TLR and major adverse cardiac events even after treatment of ISR with gamma-RT...
  79. ncbi request reprint Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts
    Jose de Ribamar Costa
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:74-8. 2005
    ..These differences are independent of stent manufacturer, length, diameter, and deployment pressure...
  80. ncbi request reprint Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, New York, USA
    Kidney Int 67:706-13. 2005
    ..The relationship between low hematocrit and contrast-induced nephropathy has not been investigated...
  81. ncbi request reprint The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization procedures
    G Dangas
    Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, NY, USA
    Rev Port Cardiol 18:I49-53. 1999
    ..Compelling data on the central role of platelets in arterial thrombosis have made apparent the need for more potent antiplatelet agents for the treatment of patients undergoing PCI...
  82. ncbi request reprint Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications
    G Dangas
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 85:870-2, A6, A9. 2000
    ..Moreover, they correlated with persistent troponin-I elevation at follow-up, and with late myocardial infarction...
  83. ncbi request reprint Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury model
    N Kipshidze
    Lenox Hill Heart and Vascular Institute of New York and Cardiovascular Research Foundation, New York, NY, USA
    Circulation 104:1850-5. 2001
    ..Neointimal hyperplasia after PTCA is an important component of restenosis...
  84. ncbi request reprint Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)
    Ricardo A Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    Am J Cardiol 95:113-6. 2005
    ..There was 1 in-stent and 1 in-segment (proximal edge) restenosis in the metallic stent group. There was no stent thrombosis or aneurysm formation at follow-up in either group...
  85. ncbi request reprint Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 93:963-8. 2004
    ..A less aggressive stent implantation strategy in SVGs than in native coronary lesions appears prudent...
  86. doi request reprint Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention
    Emilia Solinas
    Division of Cardiology, Parma University Hospital, Italy
    Am J Cardiol 102:311-5. 2008
    ..Treatment with either repeated DES implantation or balloon angioplasty for DES-ISR was safe and associated with low overall rates of target-lesion revascularization and major adverse cardiac events at 1 year...
  87. ncbi request reprint Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting
    Deepak L Bhatt
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    J Am Coll Cardiol 39:9-14. 2002
    ..We sought to determine whether clopidogrel is at least as efficacious as ticlopidine...
  88. ncbi request reprint Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy)
    Paul S Teirstein
    Scripps Clinic, La Jolla, California, USA
    Am J Cardiol 96:500-5. 2005
    ..By multivariate analysis, use of GP IIb/IIIa inhibitors during stenting with the TAXUS stent was an independent predictor of CK-MB increases >3 times the normal level. Further studies are warranted...
  89. ncbi request reprint Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure
    Luis Gruberg
    Department of Cardiology, Rambam Medical Center, Haifa, Israel
    Catheter Cardiovasc Interv 55:66-72. 2002
    ..0001), and CRF (OR = 1.74; P = 0.003) were independent correlates of increased late mortality. Therefore, PCI in patients with impaired renal function, whether on dialysis or not, is associated with poor in-hospital and 1-year survival...
  90. ncbi request reprint Editorial commentary: in-stent restenosis and cutting balloon
    George Dangas
    J Invasive Cardiol 14:297-8. 2002
  91. ncbi request reprint Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials
    Jeffrey W Moses
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10032, USA
    J Am Coll Cardiol 47:2164-71. 2006
    ....
  92. ncbi request reprint Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach
    Eugenia Nikolsky
    Cardiovascular Research Foundation, Columbia University Medical Center, Herbert Irving Pavilion, 5th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA
    Eur Heart J 28:1936-45. 2007
    ..Major bleeding after percutaneous coronary intervention (PCI) is an independent risk factor for early and late mortality. We developed and validated a risk score predictive of major bleeding after PCI using the femoral approach...
  93. ncbi request reprint Thrombosis after implantation of drug-eluting stents
    Ioannis Iakovou
    Army Hospital of Thessaloniki, Greece and Euromedica, Blue Cross, Greece
    Hellenic J Cardiol 47:31-8. 2006